
Justin Timberlake diagnosed with Lyme disease during 'Forget Tomorrow World Tour'
The singer posted a bunch of pictures from his tour while detailing his diagnosis to coincide with the conclusion of his global tour.
Fans recently noticed that Timberlake appeared sluggish and low-energy during performances on the international leg of the trek, which he suggested was due to the nerve damage and fatigue he experienced from Lyme disease, as per his Instagram post.
'I've been battling some health issues, and was diagnosed with Lyme Disease-which I don't say so you feel bad for me - but to shed some light on what I've been up against behind the scenes. If you've experienced this disease or know someone who has- then you're aware: Living with this can be relentlessly debilitating, both mentally and physically,' wrote Justin Timberlake.
The 'Mirrors' singer described his mindset when he first got diagnosed with Lyme disease, explaining that he contemplated stopping the tour but ultimately decided to continue for the love of performance.
'When I first got the diagnosis, I was shocked for sure. But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness. I was faced with a personal decision. Stop touring? Or, keep going and figure it out. I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going,' said Justin Timberlake.
The singer further said that he was hesitant to talk about his personal struggles.
'I was reluctant to talk about this because I was always raised to keep something like this to yourself. But I am trying to be more transparent about my struggles so that they aren't misinterpreted. Sharing all of this with the hope that we can all find a way to be more connected. I'd like to do my part to help others experiencing this disease too,' wrote Justin Timberlake.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBC
6 hours ago
- CBC
Lyme disease more common as warmer summers bring more ticks
Singer Justin Timberlake is the latest celebrity to announce he's been battling Lyme disease, but experts say cases of the tick-borne illness are on the rise in Canada, too, largely because warmer summers have extended tick season.


CBC
18 hours ago
- CBC
Tick-borne diseases on rise due to warmer temperatures, experts say
With warmer weather, Health Canada is warning about the growing risk of tick-borne illnesses like Lyme disease now spreading to new regions. Dr. Christopher Labos weighs in and also talks about staying safe amid widespread air quality alerts due to wildfire smoke.


Canada News.Net
a day ago
- Canada News.Net
"We will pay as low as the lowest nation in the world," Trump on Most Favoured Nation drug pricing plan
Washington DC [US], August 4 (ANI): US President Donald Trump while speaking to reporters on Sunday (local time), said that he aimed to lower the prices of pharmaceutical drugs with the Most Favoured Nation prescription drug pricing plan. Trump said before boarding Air Force One in Allentown, Pennsylvania that the US will pay the lowest price just like other European nations do. 'We want the same price as Europe gets. We want the same price as other countries get ... We will pay as low as the lowest nation in the world. The next big move is going to be the price of drugs because you could buy something in London or in Germany some place... sometimes 1/10th the price of what it costs to buy it in New York... We're not doing that anymore,' he said. Trump is increasing pressure on major drugmakers to bring their US prices in line with the far lower ones available to patients in other countries. However, industry experts don't expect the pharmaceutical companies to comply, CNN reported. Earlier on Thursday, Trump sent letters to 17 major pharmaceutical company CEOs on with a list of demands, including that the manufacturers extend 'Most Favored Nation' pricing, the lowest price paid for a drug in a peer country, to all drugs provided to Medicaid enrollees. The US president gave the companies 60 days to comply. The directive stems from an executive order Trump signed in May, when he demanded drugmakers start offering US patients lower prices or face consequences. Meanwhile the US President continued to bat for the tariff policy saying that it would bring down debt. 'We're going to pay down debt. We have a lot of money coming in, much more money than the country's ever seen, by hundreds of billions of dollars... we should've done this many years ago,' he said. (ANI)